Home >> Marketplace Directory >> Illumina receives EUA for sequencing-based COVID-19 dx

Illumina receives EUA for sequencing-based COVID-19 dx

image_pdfCreate PDF

The workflow accommodates up to 3,072 samples per NovaSeq run, leveraging the S4 flow cell, and includes steps for viral RNA extraction, RNA-to-CDNA conversion, PCR, library preparation, sequencing, and report generation. Components include the NovaSeq 6000 coupled with Illumina Tagmentation library preparation technology and the Dragen COVIDSeq Test Pipeline for rapid reporting.

Illumina, 858-202-4566

CAP TODAY
X